Our Home Miami

Senior Home Franchises

Alzheimers Legal Resource Centers goal is to provide answers to the long-term care crisis facing millions of Americans. the question is no longer what should I do with my assets when I die? The most important question these days, and one which very few lawyers are prepared to deal with is: what happens when I outlive my money and my assets?

Smart Genetics has the exclusive rights to test for the APOE gene, the only clinically accepted genetic risk factor for late onset Alzheimer's.

Golfers can support the McKeown Foundation by purchasing tickets to the event for $325. In addition, there are a wide variety of attractive individual and corporate sponsorship packages ranging from $150 to $15,000 that include a variety of extras such as advertisement and acknowledgement on the event Web site. Golfers will receive gift packs that include a variety of useful golf accessories.

Dr. Dave' is author of 'Total Memory Care' (www.helpmemoryloss.com), and recommends that all patients with memory problems should first ask their doctor if any of the medications they are on have anticholinergic side effects, if so, ask if there is an alternative.

For additional information on Health Care Group, please log on to www.healthcaregrp.com.

Unfortunately, Willie noted "there are two sets of laws out there: one for the unrepresented and one for the represented and well informed. That's why I created the Alzheimer's Legal Resource Center-so that the public is informed." He went on to add that "while the laws applicable to long-term care planning such as Medicaid vary from state to state, the message is the same: seek out a qualified Elder Law attorney in your area to assist you with your planning, and always plan as early as possible."

The Haubner Family Story - Arthritis
Friday, 5/9, 11:00am
Tuesday, 5/13, 2:00pm
Thursday, 5/15, 9:00pm

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, leukemia, lymphoma, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient. For more information, please visit www.FeinsteinInstitute.org or www.feinsteininstitute.typepad.com. The institute also publishes the scientific journal Molecular Medicine and a monthly podcast of the latest findings in the journal at www.molmed.org.

The strongest risk gene identified for late-onset Alzheimer’s is Apo-E4. Just one copy of this gene variant triples the risk of the disease. No one knows precisely why or how it works to increase the risk for the disease. Dr. Marambaud and his colleagues are excited by their discovery, because there are medicines that block calcium channels and it would be easier to develop targeted therapies.

For interviews with Mr. Awad, contact Al Shaine at (202) 478-3562

“The performance of automated segmentation is not only similar to that of the manual method, it is much faster,” Dr. Colliot said. “It can be performed within a few minutes versus an hour.”

Contact:
Brian Willie, Partner
Law Office of Willie & Dasher
512-478-0834
Law Office of Willie & Dasher